The objectives of this study were to evaluate the hematopoietic response to darbepoetin alfa, evaluate the effects of every-three-week administration, and assess the quality of life using the ...

According to the results of a single-center, prospective, crossover study, darbepoetin alfa—a hyperglycosylated, and therefore longer-acting, derivative of epoetin—is a more effective ...